Clinical Trials List
2024-05-01 - 2028-12-31
Phase II/III
Recruiting5
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Pei-Jen Lou Division of Hematology & Oncology
- 王郁棻 Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
- Hsiang-Fong Kao Division of Hematology & Oncology
- RUEY-LONG HONG Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tien-Hua Chen Division of Hematology & Oncology
- Mu-Hsin Chang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 王閔宏 Division of Hematology & Oncology
- Tsung-Jang Yeh Division of Hematology & Oncology
- Jeng-Shiun Du Division of Hematology & Oncology
- 高育青 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ching Yun Hsieh Division of Hematology & Oncology
- 陳珈妤 Division of Hematology & Oncology
- Yu-Min Liao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 葉智華 Division of Hematology & Oncology
- Li-Yu Lee Division of Hematology & Oncology
- Chi-Ting Liau Division of Hematology & Oncology
- Cheng-Lung Hsu Division of Hematology & Oncology
- Chia-Hsun Hsieh Division of Hematology & Oncology
- 廖俊達 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
500 participants
